Skip to main content
Erschienen in: Die Ophthalmologie 1/2023

13.12.2022 | Peeling | Leitlinien, Stellungnahmen und Empfehlungen

Makulaforamen und vitreomakuläre Traktion

S1-Leitlinie der Deutschen Ophthalmologischen Gesellschaft (DOG), der Retinologischen Gesellschaft (RG) und des Berufsverbands der Augenärzte Deutschlands (BVA). Version: 22. September 2022

verfasst von: Deutsche Ophthalmologische Gesellschaft e. V. (DOG), Retinologische Gesellschaft e. V. (RG), Berufsverband der Augenärzte Deutschlands e. V. (BVA)

Erschienen in: Die Ophthalmologie | Sonderheft 1/2023

Einloggen, um Zugang zu erhalten

Auszug

Hilfestellung bei einer sinnvollen Gestaltung der Diagnostik von 2 wichtigen Krankheitsgruppen und Hilfen bei der Auswahl möglicher Therapien. …
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Bartz-Schmidt KU, Bertram B, Bornfeld N, Bresgen M, Eter N, Feltgen N et al (2013) Current statement of the German ophthalmological society, the retina society and the professional association of German ophthalmologists for therapeutic intravitreal application of ocriplasmin (JETREA ®) in ophthalmology (May 2013). Klin Monbl Augenheilkd 230(6):629–634 Bartz-Schmidt KU, Bertram B, Bornfeld N, Bresgen M, Eter N, Feltgen N et al (2013) Current statement of the German ophthalmological society, the retina society and the professional association of German ophthalmologists for therapeutic intravitreal application of ocriplasmin (JETREA ®) in ophthalmology (May 2013). Klin Monbl Augenheilkd 230(6):629–634
2.
Zurück zum Zitat Berufsverband der Augenärzte Deutschlands e. V. (BVA), Deutsche Ophthalmologische Gesellschaft (DOG), Retinologische Gesellschaft e. V. (RG) (2021) Statement of the professional association of German ophthalmologists (BVA), the German ophthalmological society (DOG) and the retinological society (RG) on the development, diagnostics and treatment of epiretinal gliosis : status october 2020. Ophthalmologe 118(2):121–138CrossRef Berufsverband der Augenärzte Deutschlands e. V. (BVA), Deutsche Ophthalmologische Gesellschaft (DOG), Retinologische Gesellschaft e. V. (RG) (2021) Statement of the professional association of German ophthalmologists (BVA), the German ophthalmological society (DOG) and the retinological society (RG) on the development, diagnostics and treatment of epiretinal gliosis : status october 2020. Ophthalmologe 118(2):121–138CrossRef
3.
Zurück zum Zitat Berufsverband der Augenärzte Deutschlands e. V., Deutsche Ophthalmologische Gesellschaft, Retinologische Gesellschaft e. V. (2017) Quality assurance of optical coherence tomography for diagnostics of the fundus : positional statement of the BVA, DOG and RG. Ophthalmologe 114(7):617–624 Berufsverband der Augenärzte Deutschlands e. V., Deutsche Ophthalmologische Gesellschaft, Retinologische Gesellschaft e. V. (2017) Quality assurance of optical coherence tomography for diagnostics of the fundus : positional statement of the BVA, DOG and RG. Ophthalmologe 114(7):617–624
4.
Zurück zum Zitat Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA et al (2020) Idiopathic macular hole preferred practice pattern. Ophthalmology 127(2):P184–222CrossRef Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA et al (2020) Idiopathic macular hole preferred practice pattern. Ophthalmology 127(2):P184–222CrossRef
5.
Zurück zum Zitat Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA et al (2020) Idiopathic epiretinal membrane and vitreomacular traction preferred practice pattern. Ophthalmology 127(2):P145–83CrossRef Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA et al (2020) Idiopathic epiretinal membrane and vitreomacular traction preferred practice pattern. Ophthalmology 127(2):P145–83CrossRef
6.
Zurück zum Zitat Gass JD (1995) Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol 119(6):752–759CrossRef Gass JD (1995) Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol 119(6):752–759CrossRef
7.
Zurück zum Zitat Duker JS, Kaiser PK, Binder S, de Smet MD, Gaudric A, Reichel E et al (2013) The international vitreomacular traction study group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology 120(12):2611–2619CrossRef Duker JS, Kaiser PK, Binder S, de Smet MD, Gaudric A, Reichel E et al (2013) The international vitreomacular traction study group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology 120(12):2611–2619CrossRef
8.
Zurück zum Zitat Darian-Smith E, Howie AR, Allen PL, Vote BJ (2016) Tasmanian macular hole study: whole population-based incidence of full thickness macular hole. Clin Exp Ophthalmol 44(9):812–816CrossRef Darian-Smith E, Howie AR, Allen PL, Vote BJ (2016) Tasmanian macular hole study: whole population-based incidence of full thickness macular hole. Clin Exp Ophthalmol 44(9):812–816CrossRef
9.
Zurück zum Zitat McCannel CA, Ensminger JL, Diehl NN, Hodge DN (2009) Population-based incidence of macular holes. Ophthalmology 116(7):1366–1369CrossRef McCannel CA, Ensminger JL, Diehl NN, Hodge DN (2009) Population-based incidence of macular holes. Ophthalmology 116(7):1366–1369CrossRef
10.
Zurück zum Zitat Schuster AKG, Kluck AK, Korb CA, Stoffelns B, Nickels S, Schulz A et al (2020) Characteristics and pathologies of the vitreo-macular interface-results from the Gutenberg Health Study. Acta Ophthalmol 98(3):e273–81CrossRef Schuster AKG, Kluck AK, Korb CA, Stoffelns B, Nickels S, Schulz A et al (2020) Characteristics and pathologies of the vitreo-macular interface-results from the Gutenberg Health Study. Acta Ophthalmol 98(3):e273–81CrossRef
11.
Zurück zum Zitat Meuer SM, Myers CE, Klein BEK, Swift MK, Huang Y, Gangaputra S et al (2015) The epidemiology of vitreoretinal interface abnormalities as detected by spectral-domain optical coherence tomography: the beaver dam eye study. Ophthalmology 122(4):787–795CrossRef Meuer SM, Myers CE, Klein BEK, Swift MK, Huang Y, Gangaputra S et al (2015) The epidemiology of vitreoretinal interface abnormalities as detected by spectral-domain optical coherence tomography: the beaver dam eye study. Ophthalmology 122(4):787–795CrossRef
12.
Zurück zum Zitat Liesenborghs I, De Clerck EEB, Berendschot TTJM, Goezinne F, Schram MT, Henry RMA et al (2018) Prevalence of optical coherence tomography detected vitreomacular interface disorders: the Maastricht study. Acta Ophthalmol 96(7):729–736CrossRef Liesenborghs I, De Clerck EEB, Berendschot TTJM, Goezinne F, Schram MT, Henry RMA et al (2018) Prevalence of optical coherence tomography detected vitreomacular interface disorders: the Maastricht study. Acta Ophthalmol 96(7):729–736CrossRef
13.
Zurück zum Zitat Lindtjørn B, Krohn J, Austeng D, Fossen K, Varhaug P, Basit S et al (2019) Nonsupine positioning after macular hole surgery: a prospective multicenter study. Ophthalmol Retina 3(5):388–392CrossRef Lindtjørn B, Krohn J, Austeng D, Fossen K, Varhaug P, Basit S et al (2019) Nonsupine positioning after macular hole surgery: a prospective multicenter study. Ophthalmol Retina 3(5):388–392CrossRef
14.
Zurück zum Zitat Sugiyama A, Imasawa M, Chiba T, Iijima H (2012) Reappraisal of spontaneous closure rate of idiopathic full-thickness macular holes. Open Ophthalmol J 6:73–74CrossRef Sugiyama A, Imasawa M, Chiba T, Iijima H (2012) Reappraisal of spontaneous closure rate of idiopathic full-thickness macular holes. Open Ophthalmol J 6:73–74CrossRef
15.
Zurück zum Zitat Parravano M, Giansanti F, Eandi CM, Yap YC, Rizzo S, Virgili G (2015) Vitrectomy for idiopathic macular hole. Cochrane Database Syst Rev 5:CD9080 Parravano M, Giansanti F, Eandi CM, Yap YC, Rizzo S, Virgili G (2015) Vitrectomy for idiopathic macular hole. Cochrane Database Syst Rev 5:CD9080
16.
Zurück zum Zitat Dugel PU, Tolentino M, Feiner L, Kozma P, Leroy A (2016) Results of the 2‑year ocriplasmin for treatment for symptomatic vitreomacular adhesion including macular hole (OASIS) randomized trial. Ophthalmology 123(10):2232–2247CrossRef Dugel PU, Tolentino M, Feiner L, Kozma P, Leroy A (2016) Results of the 2‑year ocriplasmin for treatment for symptomatic vitreomacular adhesion including macular hole (OASIS) randomized trial. Ophthalmology 123(10):2232–2247CrossRef
17.
Zurück zum Zitat Watzke RC, Allen L (1969) Subjective slitbeam sign for macular disease. Am J Ophthalmol 68(3):449–453CrossRef Watzke RC, Allen L (1969) Subjective slitbeam sign for macular disease. Am J Ophthalmol 68(3):449–453CrossRef
18.
Zurück zum Zitat DeCroos FC, Toth CA, Folgar FA, Pakola S, Stinnett SS, Heydary CS et al (2012) Characterization of vitreoretinal interface disorders using OCT in the interventional phase 3 trials of ocriplasmin. Invest Ophthalmol Vis Sci 53(10):6504–6511CrossRef DeCroos FC, Toth CA, Folgar FA, Pakola S, Stinnett SS, Heydary CS et al (2012) Characterization of vitreoretinal interface disorders using OCT in the interventional phase 3 trials of ocriplasmin. Invest Ophthalmol Vis Sci 53(10):6504–6511CrossRef
19.
Zurück zum Zitat Tornambe PE, Poliner LS, Cohen RG (1998) Definition of macular hole surgery end points: elevated/open, flat/open, flat/closed. Retina 18(3):286–287CrossRef Tornambe PE, Poliner LS, Cohen RG (1998) Definition of macular hole surgery end points: elevated/open, flat/open, flat/closed. Retina 18(3):286–287CrossRef
20.
Zurück zum Zitat Kang SW, Ahn K, Ham DI (2003) Types of macular hole closure and their clinical implications. Br J Ophthalmol 87(8):1015–1019CrossRef Kang SW, Ahn K, Ham DI (2003) Types of macular hole closure and their clinical implications. Br J Ophthalmol 87(8):1015–1019CrossRef
21.
Zurück zum Zitat Hubschman JP, Govetto A, Spaide RF, Schumann R, Steel D, Figueroa MS et al (2020) Optical coherence tomography-based consensus definition for lamellar macular hole. Br J Ophthalmol 104(12):1741–1747CrossRef Hubschman JP, Govetto A, Spaide RF, Schumann R, Steel D, Figueroa MS et al (2020) Optical coherence tomography-based consensus definition for lamellar macular hole. Br J Ophthalmol 104(12):1741–1747CrossRef
22.
Zurück zum Zitat Compera D, Entchev E, Haritoglou C, Scheler R, Mayer WJ, Wolf A et al (2015) Lamellar hole-associated epiretinal proliferation in comparison to epiretinal membranes of macular pseudoholes. Am J Ophthalmol 160(2):373–384.e1CrossRef Compera D, Entchev E, Haritoglou C, Scheler R, Mayer WJ, Wolf A et al (2015) Lamellar hole-associated epiretinal proliferation in comparison to epiretinal membranes of macular pseudoholes. Am J Ophthalmol 160(2):373–384.e1CrossRef
23.
Zurück zum Zitat Chehaibou I, Hubschman JP, Kasi S, Su D, Joseph A, Prasad P et al (2021) Spontaneous conversion of lamellar macular holes to full-thickness macular holes: clinical features and surgical outcomes. Ophthalmol Retina 5(10):1009–1016CrossRef Chehaibou I, Hubschman JP, Kasi S, Su D, Joseph A, Prasad P et al (2021) Spontaneous conversion of lamellar macular holes to full-thickness macular holes: clinical features and surgical outcomes. Ophthalmol Retina 5(10):1009–1016CrossRef
24.
Zurück zum Zitat Maier M, Schumann R, Friedrich J, Klaas J, Haritoglou C (2021) Biomarkers in full-thickness and lamellar defects of the macula. Ophthalmologe 118(4):321–336CrossRef Maier M, Schumann R, Friedrich J, Klaas J, Haritoglou C (2021) Biomarkers in full-thickness and lamellar defects of the macula. Ophthalmologe 118(4):321–336CrossRef
25.
Zurück zum Zitat Essex RW, Hunyor AP, Moreno-Betancur M, Yek JTO, Kingston ZS, Campbell WG et al (2018) The visual outcomes of macular hole surgery: a registry-based study by the Australian and new zealand society of retinal specialists. Ophthalmol Retina 2(11):1143–1151CrossRef Essex RW, Hunyor AP, Moreno-Betancur M, Yek JTO, Kingston ZS, Campbell WG et al (2018) The visual outcomes of macular hole surgery: a registry-based study by the Australian and new zealand society of retinal specialists. Ophthalmol Retina 2(11):1143–1151CrossRef
26.
Zurück zum Zitat Jackson TL, Nicod E, Angelis A, Grimaccia F, Prevost AT, Simpson ARH et al (2013) Pars plana vitrectomy for vitreomacular traction syndrome: a systematic review and metaanalysis of safety and efficacy. Retina 33(10):2012–2017CrossRef Jackson TL, Nicod E, Angelis A, Grimaccia F, Prevost AT, Simpson ARH et al (2013) Pars plana vitrectomy for vitreomacular traction syndrome: a systematic review and metaanalysis of safety and efficacy. Retina 33(10):2012–2017CrossRef
27.
Zurück zum Zitat de Bustros S (1994) Vitrectomy for prevention of macular holes. Results of a randomized multicenter clinical trial. Vitrectomy for prevention of macular hole study group. Ophthalmology 101(6):1055–1059 (discussion 1060) de Bustros S (1994) Vitrectomy for prevention of macular holes. Results of a randomized multicenter clinical trial. Vitrectomy for prevention of macular hole study group. Ophthalmology 101(6):1055–1059 (discussion 1060)
28.
Zurück zum Zitat Parolini B, Michalewska Z, Hardin JS, Ducournau D, Othman IS, Faramawi MF et al (2020) European vitreoretinal society macular hole study, prognostic factors for anatomical and functional success. Med Hypothesis Discov Innov Ophthalmol 9(3):198–207CrossRef Parolini B, Michalewska Z, Hardin JS, Ducournau D, Othman IS, Faramawi MF et al (2020) European vitreoretinal society macular hole study, prognostic factors for anatomical and functional success. Med Hypothesis Discov Innov Ophthalmol 9(3):198–207CrossRef
29.
Zurück zum Zitat Steel DH, Donachie PHJ, Aylward GW, Laidlaw DA, Williamson TH, Yorston D et al (2021) Factors affecting anatomical and visual outcome after macular hole surgery: findings from a large prospective UK cohort. Eye (Lond) 35(1):316–325CrossRef Steel DH, Donachie PHJ, Aylward GW, Laidlaw DA, Williamson TH, Yorston D et al (2021) Factors affecting anatomical and visual outcome after macular hole surgery: findings from a large prospective UK cohort. Eye (Lond) 35(1):316–325CrossRef
30.
Zurück zum Zitat Paques M, Chastang C, Mathis A, Sahel J, Massin P, Dosquet C et al (1999) Effect of autologous platelet concentrate in surgery for idiopathic macular hole: results of a multicenter, double-masked, randomized trial. Platelets in macular hole surgery group. Ophthalmology 106(5):932–938CrossRef Paques M, Chastang C, Mathis A, Sahel J, Massin P, Dosquet C et al (1999) Effect of autologous platelet concentrate in surgery for idiopathic macular hole: results of a multicenter, double-masked, randomized trial. Platelets in macular hole surgery group. Ophthalmology 106(5):932–938CrossRef
31.
Zurück zum Zitat Michalewska Z, Michalewski J, Adelman RA, Nawrocki J (2010) Inverted internal limiting membrane flap technique for large macular holes. Ophthalmology 117(10):2018–2025CrossRef Michalewska Z, Michalewski J, Adelman RA, Nawrocki J (2010) Inverted internal limiting membrane flap technique for large macular holes. Ophthalmology 117(10):2018–2025CrossRef
32.
Zurück zum Zitat Eckardt C, Eckardt U, Groos S, Luciano L, Reale E (1997) Removal of the internal limiting membrane in macular holes. Clinical and morphological findings. Ophthalmologe 94(8):545–551CrossRef Eckardt C, Eckardt U, Groos S, Luciano L, Reale E (1997) Removal of the internal limiting membrane in macular holes. Clinical and morphological findings. Ophthalmologe 94(8):545–551CrossRef
33.
Zurück zum Zitat Lois N, Burr J, Norrie J, Vale L, Cook J, McDonald A et al (2011) Internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole: a pragmatic randomized controlled trial. Invest Ophthalmol Vis Sci 52(3):1586–1592CrossRef Lois N, Burr J, Norrie J, Vale L, Cook J, McDonald A et al (2011) Internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole: a pragmatic randomized controlled trial. Invest Ophthalmol Vis Sci 52(3):1586–1592CrossRef
34.
Zurück zum Zitat Spiteri Cornish K, Lois N, Scott NW, Burr J, Cook J, Boachie C et al (2014) Vitrectomy with internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole. Ophthalmology 121(3):649–655CrossRef Spiteri Cornish K, Lois N, Scott NW, Burr J, Cook J, Boachie C et al (2014) Vitrectomy with internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole. Ophthalmology 121(3):649–655CrossRef
35.
Zurück zum Zitat Tadayoni R, Holz FG, Zech C, Liu X, Spera C, Stalmans P (2019) Assessment of anatomical and functional outcomes WITH ocriplasmin treatment IN patients WITH vitreomacular traction WITH or without MacUlar holes: results of Oviid‑1 trial. Retina 39(12):2341–2352CrossRef Tadayoni R, Holz FG, Zech C, Liu X, Spera C, Stalmans P (2019) Assessment of anatomical and functional outcomes WITH ocriplasmin treatment IN patients WITH vitreomacular traction WITH or without MacUlar holes: results of Oviid‑1 trial. Retina 39(12):2341–2352CrossRef
36.
Zurück zum Zitat Chatziralli IP, Theodossiadis PG, Steel DHW (2018) Internal limiting membrane peeling IN MacUlar hole surgery; WHY, when, and how? Retina 38(5):870–882CrossRef Chatziralli IP, Theodossiadis PG, Steel DHW (2018) Internal limiting membrane peeling IN MacUlar hole surgery; WHY, when, and how? Retina 38(5):870–882CrossRef
37.
Zurück zum Zitat Modi A, Giridhar A, Gopalakrishnan M (2017) Comparative analysis of outcomes WITH variable diameter internal limiting membrane peeling IN surgery for idiopathic MacUlar hole repair. Retina 37(2):265–273CrossRef Modi A, Giridhar A, Gopalakrishnan M (2017) Comparative analysis of outcomes WITH variable diameter internal limiting membrane peeling IN surgery for idiopathic MacUlar hole repair. Retina 37(2):265–273CrossRef
38.
Zurück zum Zitat Bae K, Kang SW, Kim JH, Kim SJ, Kim JM, Yoon JM (2016) Extent of internal limiting membrane peeling and its impact on macular hole surgery outcomes: a randomized trial. Am J Ophthalmol 169:179–188CrossRef Bae K, Kang SW, Kim JH, Kim SJ, Kim JM, Yoon JM (2016) Extent of internal limiting membrane peeling and its impact on macular hole surgery outcomes: a randomized trial. Am J Ophthalmol 169:179–188CrossRef
39.
Zurück zum Zitat Kanda S, Uemura A, Yamashita T, Kita H, Yamakiri K, Sakamoto T (2004) Visual field defects after intravitreous administration of indocyanine green in macular hole surgery. Arch Ophthalmol 122(10):1447–1451CrossRef Kanda S, Uemura A, Yamashita T, Kita H, Yamakiri K, Sakamoto T (2004) Visual field defects after intravitreous administration of indocyanine green in macular hole surgery. Arch Ophthalmol 122(10):1447–1451CrossRef
40.
Zurück zum Zitat Tsuiki E, Fujikawa A, Miyamura N, Yamada K, Mishima K, Kitaoka T (2007) Visual field defects after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 143(4):704–705CrossRef Tsuiki E, Fujikawa A, Miyamura N, Yamada K, Mishima K, Kitaoka T (2007) Visual field defects after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 143(4):704–705CrossRef
41.
Zurück zum Zitat Rodrigues EB, Meyer CH, Mennel S, Farah ME (2007) Mechanisms of intravitreal toxicity of indocyanine green dye: implications for chromovitrectomy. Retina 27(7):958–970CrossRef Rodrigues EB, Meyer CH, Mennel S, Farah ME (2007) Mechanisms of intravitreal toxicity of indocyanine green dye: implications for chromovitrectomy. Retina 27(7):958–970CrossRef
42.
Zurück zum Zitat Lindtjørn B, Krohn J, Haugstad M, Stene-Johansen I, Austeng D, Basit S et al (2022) Air versus sulfur hexafluoride gas tamponade for small and medium sized macular holes: a randomized noninferiority trial. Ophthalmol Retina 6(9):828–834CrossRef Lindtjørn B, Krohn J, Haugstad M, Stene-Johansen I, Austeng D, Basit S et al (2022) Air versus sulfur hexafluoride gas tamponade for small and medium sized macular holes: a randomized noninferiority trial. Ophthalmol Retina 6(9):828–834CrossRef
43.
Zurück zum Zitat Rishi P, Rishi E, Bhende P, Bhende M, Kandle K, Attiku Y et al (2022) A prospective, interventional study comparing the outcomes of macular hole surgery in eyes randomized to C3F8, C2F6, or SF6 gas tamponade. Int Ophthalmol 42(5):1515–1521CrossRef Rishi P, Rishi E, Bhende P, Bhende M, Kandle K, Attiku Y et al (2022) A prospective, interventional study comparing the outcomes of macular hole surgery in eyes randomized to C3F8, C2F6, or SF6 gas tamponade. Int Ophthalmol 42(5):1515–1521CrossRef
44.
Zurück zum Zitat Modi A, Giridhar A, Gopalakrishnan M (2017) Sulfurhexafluoride (SF6) versus perfluoropropane (C3F8) gas as tamponade IN MacUlar hole surgery. Retina 37(2):283–290CrossRef Modi A, Giridhar A, Gopalakrishnan M (2017) Sulfurhexafluoride (SF6) versus perfluoropropane (C3F8) gas as tamponade IN MacUlar hole surgery. Retina 37(2):283–290CrossRef
45.
Zurück zum Zitat Essex RW, Kingston ZS, Moreno-Betancur M, Shadbolt B, Hunyor AP, Campbell WG et al (2016) The effect of postoperative face-down positioning and of long- versus short-acting gas in macular hole surgery: results of a registry-based study. Ophthalmology 123(5):1129–1136CrossRef Essex RW, Kingston ZS, Moreno-Betancur M, Shadbolt B, Hunyor AP, Campbell WG et al (2016) The effect of postoperative face-down positioning and of long- versus short-acting gas in macular hole surgery: results of a registry-based study. Ophthalmology 123(5):1129–1136CrossRef
47.
Zurück zum Zitat Solebo AL, Lange CA, Bunce C, Bainbridge JW (2011) Face-down positioning or posturing after macular hole surgery. Cochrane Database Syst Rev 12:CD8228 Solebo AL, Lange CA, Bunce C, Bainbridge JW (2011) Face-down positioning or posturing after macular hole surgery. Cochrane Database Syst Rev 12:CD8228
48.
Zurück zum Zitat Ye T, Yu JG, Liao L, Liu L, Xia T, Yang LL (2019) Macular hole surgery recovery with and without face-down posturing: a meta-analysis of randomized controlled trials. BMC Ophthalmol 19(1):265CrossRef Ye T, Yu JG, Liao L, Liu L, Xia T, Yang LL (2019) Macular hole surgery recovery with and without face-down posturing: a meta-analysis of randomized controlled trials. BMC Ophthalmol 19(1):265CrossRef
49.
Zurück zum Zitat Pasu S, Bell L, Zenasni Z, Lanz D, Simmonds IA, Thompson A et al (2020) Facedown positioning following surgery for large full-thickness macular hole: a multicenter randomized clinical trial. JAMA Ophthalmol 138(7):725–730CrossRef Pasu S, Bell L, Zenasni Z, Lanz D, Simmonds IA, Thompson A et al (2020) Facedown positioning following surgery for large full-thickness macular hole: a multicenter randomized clinical trial. JAMA Ophthalmol 138(7):725–730CrossRef
50.
Zurück zum Zitat Alberti M, la Cour M (2016) Nonsupine positioning IN MacUlar hole surgery: a noninferiority randomized clinical trial. Retina 36(11):2072–2079CrossRef Alberti M, la Cour M (2016) Nonsupine positioning IN MacUlar hole surgery: a noninferiority randomized clinical trial. Retina 36(11):2072–2079CrossRef
51.
Zurück zum Zitat Zhang Y, Chen X, Hong L, Yan Y, Zeng M, Huang Z et al (2019) Facedown positioning after vitrectomy WILL not facilitate MacUlar hole closure based on swept-source optical coherence tomography imaging IN gas-filled eyes: a prospective, randomized comparative interventional study. Retina 39(12):2353–2359CrossRef Zhang Y, Chen X, Hong L, Yan Y, Zeng M, Huang Z et al (2019) Facedown positioning after vitrectomy WILL not facilitate MacUlar hole closure based on swept-source optical coherence tomography imaging IN gas-filled eyes: a prospective, randomized comparative interventional study. Retina 39(12):2353–2359CrossRef
52.
Zurück zum Zitat Jackson TL, Donachie PHJ, Sparrow JM, Johnston RL (2013) United Kingdom national ophthalmology database study of vitreoretinal surgery: report 2, macular hole. Ophthalmology 120(3):629–634CrossRef Jackson TL, Donachie PHJ, Sparrow JM, Johnston RL (2013) United Kingdom national ophthalmology database study of vitreoretinal surgery: report 2, macular hole. Ophthalmology 120(3):629–634CrossRef
53.
Zurück zum Zitat Jackson TL, Donachie PHJ, Johnston RL (2016) Vitreomacular traction study group. Electronic medical record database study of vitrectomy and observation for vitreomacular traction. Retina 36(10):1897–1905CrossRef Jackson TL, Donachie PHJ, Johnston RL (2016) Vitreomacular traction study group. Electronic medical record database study of vitrectomy and observation for vitreomacular traction. Retina 36(10):1897–1905CrossRef
54.
Zurück zum Zitat Stalmans P, Benz MS, Gandorfer A, Kampik A, Girach A, Pakola S et al (2012) Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med 367(7):606–615CrossRef Stalmans P, Benz MS, Gandorfer A, Kampik A, Girach A, Pakola S et al (2012) Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med 367(7):606–615CrossRef
55.
Zurück zum Zitat Khanani AM, Duker JS, Heier JS, Kaiser PK, Joondeph BC, Kozma P et al (2019) Ocriplasmin treatment leads to symptomatic vitreomacular adhesion/vitreomacular traction resolution in the real-world setting: the phase IV orbit study. Ophthalmol Retina 3(1):32–41CrossRef Khanani AM, Duker JS, Heier JS, Kaiser PK, Joondeph BC, Kozma P et al (2019) Ocriplasmin treatment leads to symptomatic vitreomacular adhesion/vitreomacular traction resolution in the real-world setting: the phase IV orbit study. Ophthalmol Retina 3(1):32–41CrossRef
56.
Zurück zum Zitat Steel DHW, Patton N, Stappler T, Karia N, Hoerauf H, Patel N et al (2021) Ocriplasmin for vitreomacular traction IN clinical practice: the inject study. Retina 41(2):266–276CrossRef Steel DHW, Patton N, Stappler T, Karia N, Hoerauf H, Patel N et al (2021) Ocriplasmin for vitreomacular traction IN clinical practice: the inject study. Retina 41(2):266–276CrossRef
57.
Zurück zum Zitat Haller JA, Stalmans P, Benz MS, Gandorfer A, Pakola SJ, Girach A et al (2015) Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials. Ophthalmology 122(1):117–122CrossRef Haller JA, Stalmans P, Benz MS, Gandorfer A, Pakola SJ, Girach A et al (2015) Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials. Ophthalmology 122(1):117–122CrossRef
58.
Zurück zum Zitat Neffendorf JE, Kirthi V, Pringle E, Jackson TL (2017) Ocriplasmin for symptomatic vitreomacular adhesion. Cochrane Database Syst Rev 10:CD11874 Neffendorf JE, Kirthi V, Pringle E, Jackson TL (2017) Ocriplasmin for symptomatic vitreomacular adhesion. Cochrane Database Syst Rev 10:CD11874
59.
Zurück zum Zitat Ha Haynes MRJ, Depla D, de la Cour MD, Lesnik-Oberstein S, Muqit MMK et al (2016) Rhegmatogenous retinal detachment following intravitreal ocriplasmin. Graefes Arch Clin Exp Ophthalmol 254(12):2333–2338CrossRef Ha Haynes MRJ, Depla D, de la Cour MD, Lesnik-Oberstein S, Muqit MMK et al (2016) Rhegmatogenous retinal detachment following intravitreal ocriplasmin. Graefes Arch Clin Exp Ophthalmol 254(12):2333–2338CrossRef
60.
Zurück zum Zitat Errera MH, Liyanage SE, Petrou P, Keane PA, Moya R, Ezra E et al (2018) A study of the natural history of vitreomacular traction syndrome by OCT. Ophthalmology 125(5):701–707CrossRef Errera MH, Liyanage SE, Petrou P, Keane PA, Moya R, Ezra E et al (2018) A study of the natural history of vitreomacular traction syndrome by OCT. Ophthalmology 125(5):701–707CrossRef
61.
Zurück zum Zitat Chan CK, Mein CE, Glassman AR, Beaulieu WT, Calhoun CT, Jaffe GJ et al (2021) Pneumatic vitreolysis with perfluoropropane for vitreomacular traction with and without macular hole: DRCR retina network protocols AG and AH. Ophthalmology 128(11):1592–1603CrossRef Chan CK, Mein CE, Glassman AR, Beaulieu WT, Calhoun CT, Jaffe GJ et al (2021) Pneumatic vitreolysis with perfluoropropane for vitreomacular traction with and without macular hole: DRCR retina network protocols AG and AH. Ophthalmology 128(11):1592–1603CrossRef
62.
Zurück zum Zitat Baumann C, Sabatino F, Zheng Y, Johannigmann-Malek N, Maier M, Kaye SB et al (2022) Anatomical and functional outcomes of pneumatic vitreolysis for treatment of vitreomacular traction with and without macular holes. Graefes Arch Clin Exp Ophthalmol 260(7):2209–2215. https://doi.org/10.1007/s00417-022-05568-yCrossRef Baumann C, Sabatino F, Zheng Y, Johannigmann-Malek N, Maier M, Kaye SB et al (2022) Anatomical and functional outcomes of pneumatic vitreolysis for treatment of vitreomacular traction with and without macular holes. Graefes Arch Clin Exp Ophthalmol 260(7):2209–2215. https://​doi.​org/​10.​1007/​s00417-022-05568-yCrossRef
63.
Zurück zum Zitat Fallico M, Jackson TL, Chronopoulos A, Hattenbach LO, Longo A, Bonfiglio V et al (2021) Factors predicting normal visual acuity following anatomically successful macular hole surgery. Acta Ophthalmol 99(3):e324–9CrossRef Fallico M, Jackson TL, Chronopoulos A, Hattenbach LO, Longo A, Bonfiglio V et al (2021) Factors predicting normal visual acuity following anatomically successful macular hole surgery. Acta Ophthalmol 99(3):e324–9CrossRef
64.
Zurück zum Zitat Tognetto D, Grandin R, Sanguinetti G, Minutola D, Di Nicola M, Di Mascio R et al (2006) Internal limiting membrane removal during macular hole surgery: results of a multicenter retrospective study. Ophthalmology 113(8):1401–1410CrossRef Tognetto D, Grandin R, Sanguinetti G, Minutola D, Di Nicola M, Di Mascio R et al (2006) Internal limiting membrane removal during macular hole surgery: results of a multicenter retrospective study. Ophthalmology 113(8):1401–1410CrossRef
66.
Zurück zum Zitat Garg A, Ballios BG, Yan P (2022) Spontaneous closure of an idiopathic full-thickness macular hole: a literature review. J Vit Ret Dis 6(5):381–390 Garg A, Ballios BG, Yan P (2022) Spontaneous closure of an idiopathic full-thickness macular hole: a literature review. J Vit Ret Dis 6(5):381–390
67.
Zurück zum Zitat Berton M, Robins J, Frigo AC, Wong R (2020) Rate of progression of idiopathic full-thickness macular holes before surgery. Eye (Lond) 34(8):1386–1391CrossRef Berton M, Robins J, Frigo AC, Wong R (2020) Rate of progression of idiopathic full-thickness macular holes before surgery. Eye (Lond) 34(8):1386–1391CrossRef
68.
Zurück zum Zitat Maguire MJ, Steel DH, Yorston D, Hind J, El-Faouri M, Jalil A et al (2021) Outcome of revision procedures for failed primary MacUlar hole surgery. Retina 41(7):1389–1395CrossRef Maguire MJ, Steel DH, Yorston D, Hind J, El-Faouri M, Jalil A et al (2021) Outcome of revision procedures for failed primary MacUlar hole surgery. Retina 41(7):1389–1395CrossRef
69.
Zurück zum Zitat Szurman P, Wakili P, Stanzel BV, Siegel R, Boden KT, Rickmann A (2021) Persistent macular holes—what is the best strategy for revision? Graefes Arch Clin Exp Ophthalmol 259(7):1781–1790CrossRef Szurman P, Wakili P, Stanzel BV, Siegel R, Boden KT, Rickmann A (2021) Persistent macular holes—what is the best strategy for revision? Graefes Arch Clin Exp Ophthalmol 259(7):1781–1790CrossRef
70.
Zurück zum Zitat Caporossi T, Tartaro R, Finocchio L, Pacini B, De Angelis L, Bacherini D et al (2021) Human amniotic membrane to treat MacUlar holes that failed to close, sulfur hexafluoride endotamponade versus air endotamponade: a prospective comparative study. Retina 41(4):735–743CrossRef Caporossi T, Tartaro R, Finocchio L, Pacini B, De Angelis L, Bacherini D et al (2021) Human amniotic membrane to treat MacUlar holes that failed to close, sulfur hexafluoride endotamponade versus air endotamponade: a prospective comparative study. Retina 41(4):735–743CrossRef
71.
Zurück zum Zitat Peng J, Chen C, Zhang H, Zhang L, Liu J, Ren J et al (2021) Long-term surgical outcomes of lens capsular flap transplantation IN the management of refractory MacUlar hole. Retina 41(4):726–734CrossRef Peng J, Chen C, Zhang H, Zhang L, Liu J, Ren J et al (2021) Long-term surgical outcomes of lens capsular flap transplantation IN the management of refractory MacUlar hole. Retina 41(4):726–734CrossRef
72.
Zurück zum Zitat Moysidis SN, Koulisis N, Adrean SD, Charles S, Chetty N, Chhablani JK et al (2021) Autologous retinal transplantation for primary and refractory macular holes and macular hole retinal detachments: the global consortium. Ophthalmology 128(5):672–685CrossRef Moysidis SN, Koulisis N, Adrean SD, Charles S, Chetty N, Chhablani JK et al (2021) Autologous retinal transplantation for primary and refractory macular holes and macular hole retinal detachments: the global consortium. Ophthalmology 128(5):672–685CrossRef
73.
Zurück zum Zitat Schaub F, Gözlügöl N, von Goscinski C, Enders P, Heindl LM, Dahlke C (2021) Outcome of autologous platelet concentrate and gas tamponade compared to heavy silicone oil tamponade in persistent macular hole surgery. Eur J Ophthalmol 31(2):664–672CrossRef Schaub F, Gözlügöl N, von Goscinski C, Enders P, Heindl LM, Dahlke C (2021) Outcome of autologous platelet concentrate and gas tamponade compared to heavy silicone oil tamponade in persistent macular hole surgery. Eur J Ophthalmol 31(2):664–672CrossRef
74.
Zurück zum Zitat Figueroa MS, Mora Cantallops A, Virgili G, Govetto A (2021) Long-term results of autologous plasma as adjuvant to pars plana vitrectomy in the treatment of high myopic full-thickness macular holes. Eur J Ophthalmol 31(5):2612–2620CrossRef Figueroa MS, Mora Cantallops A, Virgili G, Govetto A (2021) Long-term results of autologous plasma as adjuvant to pars plana vitrectomy in the treatment of high myopic full-thickness macular holes. Eur J Ophthalmol 31(5):2612–2620CrossRef
75.
Zurück zum Zitat Felfeli T, Mandelcorn ED (2019) MacUlar hole hydrodissection: surgical technique for the treatment of persistent, chronic, and large macular holes. Retina 39(4):743–752CrossRef Felfeli T, Mandelcorn ED (2019) MacUlar hole hydrodissection: surgical technique for the treatment of persistent, chronic, and large macular holes. Retina 39(4):743–752CrossRef
76.
Zurück zum Zitat Meyer CH, Szurman P, Haritoglou C, Maier M, Wolf A, Lytvynchuk L et al (2020) Application of subretinal fluid to close refractory full thickness macular holes: treatment strategies and primary outcome: Apostel study. Graefes Arch Clin Exp Ophthalmol 258(10):2151–2161CrossRef Meyer CH, Szurman P, Haritoglou C, Maier M, Wolf A, Lytvynchuk L et al (2020) Application of subretinal fluid to close refractory full thickness macular holes: treatment strategies and primary outcome: Apostel study. Graefes Arch Clin Exp Ophthalmol 258(10):2151–2161CrossRef
77.
Zurück zum Zitat Rizzo S, Genovesi-Ebert F, Vento A, Cresti F, Miniaci S, Romagnoli MC (2009) Heavy silicone oil (densiron-68) for the treatment of persistent macular holes: densiron-68 endotamponade for persistent macular holes. Graefes Arch Clin Exp Ophthalmol 247(11):1471–1476CrossRef Rizzo S, Genovesi-Ebert F, Vento A, Cresti F, Miniaci S, Romagnoli MC (2009) Heavy silicone oil (densiron-68) for the treatment of persistent macular holes: densiron-68 endotamponade for persistent macular holes. Graefes Arch Clin Exp Ophthalmol 247(11):1471–1476CrossRef
78.
Zurück zum Zitat Lappas A, Foerster AMH, Kirchhof B (2009) Use of heavy silicone oil (densiron-68) in the treatment of persistent macular holes. Acta Ophthalmol 87(8):866–870CrossRef Lappas A, Foerster AMH, Kirchhof B (2009) Use of heavy silicone oil (densiron-68) in the treatment of persistent macular holes. Acta Ophthalmol 87(8):866–870CrossRef
79.
Zurück zum Zitat Li JQ, Brinken R, Holz FG, Krohne TU (2021) Silicone oil tamponade for persistent macular holes. Eye (Lond) 35(8):2206–2212CrossRef Li JQ, Brinken R, Holz FG, Krohne TU (2021) Silicone oil tamponade for persistent macular holes. Eye (Lond) 35(8):2206–2212CrossRef
Metadaten
Titel
Makulaforamen und vitreomakuläre Traktion
S1-Leitlinie der Deutschen Ophthalmologischen Gesellschaft (DOG), der Retinologischen Gesellschaft (RG) und des Berufsverbands der Augenärzte Deutschlands (BVA). Version: 22. September 2022
verfasst von
Deutsche Ophthalmologische Gesellschaft e. V. (DOG)
Retinologische Gesellschaft e. V. (RG)
Berufsverband der Augenärzte Deutschlands e. V. (BVA)
Publikationsdatum
13.12.2022
Verlag
Springer Medizin
Schlagwörter
Peeling
Vitrektomie
Erschienen in
Die Ophthalmologie / Ausgabe Sonderheft 1/2023
Print ISSN: 2731-720X
Elektronische ISSN: 2731-7218
DOI
https://doi.org/10.1007/s00347-022-01774-5

Weitere Artikel der Sonderheft 1/2023

Die Ophthalmologie 1/2023 Zur Ausgabe

Leitlinien, Stellungnahmen und Empfehlungen

Virale anteriore Uveitis

Leitlinien, Stellungnahmen und Empfehlungen

Okuläre Graft-Versus-Host Erkrankung

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.